Regulatory briefing

Our regulatory briefings section delivers current and up-to-date legal and regulatory news relating to all aspects of the CBD industry. It covers individual regulation changes across the world, policy and governmental changes that impact the industry and technological and medical innovations that affect how the industry is regulated, to name a few.

Georgia run-off election: it looks like good news for cannabis reform

Written by Freddie Dawson || 6th January 2021 || Regulatory briefing |

Georgia
North America
United States
Policy and Politics
Regulation and Legislation
US federal regulation
Regulatory briefing
Reform of cannabis laws at federal level in the US looks to be a step closer following the likely victory of the Democratic party in run-off elections for both Senate seats in the state of Georgia ...

Opponents unlikely to derail Arizona recreational cannabis legalisation

Written by Anthony Traurig || 20th November 2020 || Regulatory briefing |

Arizona
North America
United States
Regulation and Legislation
Regulatory briefing
Voters in the US states of Arizona, Mississippi, Montana, New Jersey, and South Dakota passed ballot initiatives to legalise adult-use and/or medical cannabis in their states. However, the path from ballot initiative to law is not always clear...

Ukraine moves towards potential medical cannabis legalisation

Written by CBD-Intel || 13th November 2020 || Regulatory briefing |

Europe
Ukraine
Regulation and Legislation
Regulatory briefing
Ukraine has undergone a quick shift in opinion on medical cannabis – proceeding from a point where liberalisation of current laws was viewed as unlikely to setting up parliamentary working groups to draft a bill on legalisation ...

CBD and hemp regulation: confusion in the US

Written by CBD-Intel || 23rd October 2020 || Regulatory briefing |

North America
United States
Regulation and Legislation
Regulatory briefing
Regulation of CBD at the federal level remains confusingly divided between multiple agencies. Three main bodies have overall control of most aspects of hemp and CBD consumer product regulation ...

CBD and hemp regulation: the US DEA and its authority

Written by CBD-Intel || 23rd October 2020 || Regulatory briefing |

North America
United States
Regulation and Legislation
Regulatory briefing
The passage of the 2018 Farm Bill removed hemp and compounds derived from hemp (including CBD) from the CSA. Therefore, the DEA should have very little involvement in enforcing laws and regulations on hemp and CBD ...

CBD and hemp regulation: the US FDA and its authority

Written by CBD-Intel || 23rd October 2020 || Regulatory briefing |

North America
United States
Regulation and Legislation
Regulatory briefing
The US Food and Drug Administration (FDA) is a critical agency in the regulatory scheme of CBD products. The 2018 Farm Bill, which legalised hemp and CBD derived from it, granted the FDA the authority to regulate hemp...